Fig. 8

UBE2T confers resistance to RT in HCC patients. a CT scan images of a patient with high UBE2T level (upper panel) and a patient with low UBE2T level (lower panel), before and after RT. Red arrows indicate HCC lesions. Representative images of IHC staining for UBE2T were shown. b Tumor burden change from baseline in target lesions in 14 HCC patients received RT. The score of UBE2T in each patient was indicated. c The Working model summarizes the presented findings